Natural variation in Caenorhabditis elegans responses to the anthelmintic emodepside
Treatment of parasitic nematode infections depends primarily on the use of anthelmintics. However, this drug arsenal is limited, and resistance against most anthelmintics is widespread. Emodepside is a new anthelmintic drug effective against gastrointestinal and filarial nematodes. Nematodes that ar...
Main Authors: | Janneke Wit, Briana C. Rodriguez, Erik C. Andersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320721000154 |
Similar Items
-
Efficacy of two topical combinations containing emodepside plus praziquantel, and emodepside plus praziquantel plus tigolaner, for the treatment of troglostrongylosis in experimentally infected cats
by: Donato Traversa, et al.
Published: (2022-01-01) -
In silico analysis of the binding of anthelmintics to Caenorhabditis elegans P-glycoprotein 1
by: Marion A. David, et al.
Published: (2016-12-01) -
Potent anthelmintic activity of a colloidal nano-silver formulation (Silversol®) against the model worm Caenorhabditis elegans
by: Gemini Gajera, et al.
Published: (2023-07-01) -
Plasma pharmacokinetics of tigolaner, emodepside, and praziquantel following topical administration of a combination product (Felpreva®) and of intravenous administration of the individual active ingredients in cats
by: Norbert Mencke, et al.
Published: (2023-01-01) -
Automated, high-throughput, motility analysis in Caenorhabditis elegans and parasitic nematodes: Applications in the search for new anthelmintics
by: Steven D. Buckingham, et al.
Published: (2014-12-01)